Emine Altuntaş, Kadir Sadıkoğlu, Kübra Balçın, Gizemnur Coşkun, Hasan Şahin, Abidin Emre Tırnaksız, Mehmet Ertürk
İstanbul Medical Journal - 2026;27(2):149-154
Introduction: Fibrosis-4 index (Fib-4i) is a useful and practical indicator of fibrosis risk in chronic liver disease. The study aimed to explore the relationship between Fib-4i and major adverse cardiovascular events (MACEs) within one year in cases of inflammatory myopericardial syndrome (IMPS). Methods: Between January 2018 and December 2023, 152 patients diagnosed with IMPS were stratified into two groups based on the presence of late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging. The Fib-4i was calculated at admission, and MACEs due to IMPS were recorded at 12 months. Results: Group 1 consisted of 36 LGE-negative patients, while group 2 consisted of 116 LGE-positive patients. The Fib-4i was higher in group 2 than in group 1 (p=0.014). Furthermore, it was found that aspartate aminotransferase, high-sensitivity (hs) troponin T, N-terminal pro-brain natriuretic peptide, and C-reactive protein (CRP) were higher in group 2 than in group 1 (respectively, p=0.03, p=0.002, p=0.008, p=0.014). No difference in MACEs between groups was observed at one month, six months, and one year (p=0.581, p=0.558, p=0.665, respectively). However, a positive correlation was observed between the Fib-4i and both hs-troponin T and CRP. Conclusion: Fib-4i was higher in patients with LGE than in those without LGE. However, its predictive power for MACEs could not be demonstrated.
